Joshua R. Disbrow
2015 - Ampio Pharmaceuticals
In 2015, Joshua R. Disbrow earned a total compensation of $1.6M as Former Chief Operating Officer and Chief Executive Officer of Aytu BioScience, Inc at Ampio Pharmaceuticals.
Compensation breakdown
| Bonus | $122,500 |
|---|---|
| Option Awards | $691,948 |
| Salary | $255,587 |
| Other | $558,722 |
| Total | $1,628,757 |
Disbrow received $691.9K in option awards, accounting for 42% of the total pay in 2015.
Disbrow also received $122.5K in bonus, $255.6K in salary and $558.7K in other compensation.
Rankings
In 2015, Joshua R. Disbrow's compensation ranked 5,586th out of 13,638 executives tracked by ExecPay. In other words, Disbrow earned more than 59.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,586 out of 13,638 | 59th |
Division Manufacturing | 2,072 out of 5,187 | 60th |
Major group Chemicals And Allied Products | 748 out of 1,857 | 60th |
Industry group Drugs | 593 out of 1,531 | 61st |
Industry Pharmaceutical Preparations | 465 out of 1,179 | 61st |
Source: SEC filing on October 31, 2018.
Disbrow's colleagues
We found five more compensation records of executives who worked with Joshua R. Disbrow at Ampio Pharmaceuticals in 2015.
2015
Gregory Gould
Ampio Pharmaceuticals
Chief Financial Officer
2015
David Bar-Or
Ampio Pharmaceuticals
Chief Scientific Officer
2015
Michael Macaluso
Ampio Pharmaceuticals
Chief Executive Officer
2015
Vaughan Clift
Ampio Pharmaceuticals
Former Chief Regulatory Affairs Officer
2015
Mark McGregor
Ampio Pharmaceuticals
Chief Financial Officer
News
AYTU BIOPHARMA CEO Joshua Disbrow's 2023 pay rises 20% to $708K
May 10, 2024
AYTU BIOPHARMA CEO Joshua Disbrow's 2021 pay jumps 291% to $6.2M
April 7, 2022
AYTU BIOPHARMA CEO Joshua Disbrow's 2020 pay jumps 52% to $1.6M
April 16, 2021
AYTU BIOPHARMA CEO Joshua Disbrow's 2019 pay jumps 72% to $1M
March 5, 2020
AYTU BIOPHARMA CEO Joshua Disbrow's 2018 pay falls 42% to $606K
February 25, 2019